FY2030 Earnings Estimate for Aemetis Issued By HC Wainwright

Aemetis, Inc (NASDAQ:AMTX) – Analysts at HC Wainwright upped their FY2030 earnings estimates for shares of Aemetis in a note issued to investors on Friday, November 6th. HC Wainwright analyst A. Dayal now expects that the specialty chemicals company will earn $3.46 per share for the year, up from their previous estimate of $3.10. The consensus estimate for Aemetis’ current full-year earnings is ($0.89) per share.

Aemetis (NASDAQ:AMTX) last released its quarterly earnings results on Thursday, November 5th. The specialty chemicals company reported ($0.02) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.20) by $0.18. The business had revenue of $88.15 million for the quarter, compared to the consensus estimate of $74.20 million.

Other analysts have also recently issued reports about the company. Wall Street Zen upgraded Aemetis from a “sell” rating to a “hold” rating in a research report on Saturday, August 22nd. Weiss Ratings reiterated a “sell (e+)” rating on shares of Aemetis in a research report on Thursday, October 15th. One research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Aemetis presently has an average rating of “Hold” and a consensus price target of $11.88.

Aemetis Price Performance

Shares of AMTX stock opened at $1.73 on Monday. Aemetis has a 12-month low of $1.11 and a 12-month high of $3.80. The firm has a market capitalization of $124.85 million, a price-to-earnings ratio of -3.09 and a beta of 1.87. The business has a 50 day simple moving average of $1.66 and a 200 day simple moving average of $1.95.

Institutional Trading of Aemetis

A number of hedge funds and other institutional investors have recently made changes to their positions in AMTX. Royal Bank of Canada boosted its holdings in shares of Aemetis by 10,632.5% in the first quarter. Royal Bank of Canada now owns 8,908 shares of the specialty chemicals company’s stock valued at $28,000 after acquiring an additional 8,825 shares in the last quarter. Sanctuary Advisors LLC acquired a new position in shares of Aemetis during the first quarter valued at approximately $33,000. R Squared Ltd increased its stake in shares of Aemetis by 59.4% during the third quarter. R Squared Ltd now owns 23,616 shares of the specialty chemicals company’s stock valued at $42,000 after acquiring an additional 8,803 shares during the period. Lido Advisors LLC bought a new stake in Aemetis during the third quarter worth approximately $79,000. Finally, Renaissance Technologies LLC bought a new stake in Aemetis during the first quarter worth approximately $272,000. 27.02% of the stock is currently owned by institutional investors.

Aemetis Company Profile

Aemetis, Inc is a renewable fuels and carbon-reduction company that develops and operates projects designed to produce lower-carbon alternatives to petroleum-based fuels and reduce greenhouse-gas emissions. Its activities include renewable natural gas, ethanol, renewable diesel, and other advanced fuel technologies.

The company’s California operations include dairy-based renewable natural gas projects that capture methane from dairy waste and convert it into pipeline-quality fuel. Aemetis also operates an ethanol production facility in Keyes, California, which produces ethanol and related co-products from agricultural feedstocks.